JBYHBQIDTNHWJF-HXUWFJFHSA-N O= C (O)[C@@ H](CC1= CC= CC= C1) NS (= O)(=
O) C1= CC= C (C2= CC= CC= C2) C= C1 Chemical compound O= C (O)[C@@ H](CC1 …

(57) ABSTRACT A method that determines a physical location of an unknown position
device (UPD) in a communication network includ ing a plurality of known position devices …

Hooper (1994) FEBS Letters 354: 1-6. Examples of metal loproteinases include the matrix
metalloproteinases (MMPs) such as the collagenases (MMP1, MMP8, MMP13), the …

US7666892B2 - Metalloproteinase inhibitors - Google Patents US7666892B2 -
Metalloproteinase inhibitors - Google Patents Metalloproteinase inhibitors Download PDF …

2,327,890 A 8, 1943 Henze 2,745,875 A 5, 1956 Ehrhart et al. 3,452,040 A 6/1969 Langis
3,529,019 A 9, 1970 Suh et al. 3,849,574 A 11/1974 Suh et al. 4,241,073. A 12, 1980 …

US7754750B2 - Metalloproteinase inhibitors - Google Patents US7754750B2 -
Metalloproteinase inhibitors - Google Patents Metalloproteinase inhibitors Download PDF …

US7625934B2 - Metalloproteinase inhibitors - Google Patents US7625934B2 -
Metalloproteinase inhibitors - Google Patents Metalloproteinase inhibitors Download PDF …

US PATENT DOCUMENTS The invention provides compounds of formula (1): Wherein
2,327,890 A 8/1943 Henze R1, R2, A, A1 and B are as de? ned in the speci? cation; pro …

US7648992B2 - Hydantoin derivatives for the treatment of obstructive airway diseases - Google
Patents US7648992B2 - Hydantoin derivatives for the treatment of obstructive airway diseases …

The invention provides compounds of formula (I): wherein R'and R are as defined in the
specification; pro cesses for their preparation; pharmaceutical compositions containing …